Irinotecan Study For Cervical Cancer

• Status: Completed
• Trial end date: 2008-05-01

Summary

The purpose of the study is to evaluate the efficacy and safety of Irinotecan plus cisplatin as first-line chemotherapy for advanced or recurrent cervical cancer

• Phase: Phase 2

Details

• Lead Sponsor: Pfizer
• Treatments: Camptothecin; Cisplatin; Irinotecan